Marie Chahine

Product Development: Market Launch:
• Orchestrated the successful market launch of our Hematology/Immunology Therapy in Iraq, culminating in securing Tender 2024 and Tender 2025 contracts.
• Devised and implemented comprehensive go-to-market strategies for our hematology product in Iraq, encompassing pricing, distribution, and promotional initiatives.
• Collaborated closely with sales and medical teams to ensure seamless product launches and sustained promotional efforts.
• Facilitated the Kimadia contract signing for Y 2024 and obtained Letter of Credit (LC) approval for budget allocation.
• Prepared and delivered the brand plan presentation for my product to the Global marketing team at Sanofi France, ensuring alignment with corporate strategies and objectives.
• Executed the Go-To-Market Model plan for Y 2024 and ensured readiness of branding materials
• Conducted thorough product and marketing training for the Field based sales and medical team.
Customer Relationship Management:
• Cultivated robust relationships with key opinion leaders, particularly members of the Scientific Committee and Dr. Bassam Francis, President of the Iraqi Society of Hematology (ISOH).
• Solicited feedback and insights to continually enhance the product and address customer requirements.

Data Analysis:
• Leveraged data analytics to monitor product performance, track key performance indicators (KPIs), and drive informed decision-making.
• Regularly analyzed market trends and the competitive landscape to adapt product strategies accordingly.

Educational Initiatives:

• Develop educational materials and training programs on Sanofi Digital Platforms for healthcare professionals in IQ to enhance their understanding of our hematology product.
• Facilitate educational initiatives aimed at raising awareness about the product among physicians, patients, and caregivers.

Market Research:

• Conduct extensive research on the Multiple Myeloma market, including current treatments, competitive landscape, and emerging trends.
• Analyze patient needs, physician preferences, and market dynamics to identify opportunities and challenges.

Product Strategy:

• Develop a comprehensive product strategy that aligns with the companys overall goals and objectives.
• Define clear product positioning, target patient population, and value proposition for the hematology product.

• Collaborate with cross-functional teams, including R&D, regulatory affairs, marketing, and sales, to ensure seamless product development and launch.
• Coordinate efforts to meet regulatory requirements and ensure timely
product approvals.

Risk Management:

• Identify and assess potential risks associated with the product, including regulatory, competitive, and market-related risks.
• Develop and implement risk mitigation strategies to ensure the products success in the market.

• KOL Management: Executed comprehensive Key Opinion Leader (KOL) engagement plans, ensuring strategic alignment and robust interactions via digital and face-to-face channels.
• Scientific Support: Delivered 100% of scientific support requests, including slides, and briefing lectures, maintaining strict 24-hour response times for medical information inquiries.
• Insights Generation: Collected and leveraged KOL insights to inform brand strategy and build robust plans for Brand Plan Meetings.
• Sales Force Training: Facilitated and delivered all requested training sessions to the sales force within two weeks, enhancing their scientific knowledge and product communication skills.
• CME Activities: Organized and managed Continuing Medical Education (CME) activities, ensuring full implementation per Brand Plan and creating/adapting slide decks based on the latest medical updates.
• Data Integration: Accelerated data integration and dissemination plans, ensuring effective communication of key data throughout 2023.
• Innovative Portfolio Maximization: Led efforts to maximize Sanofis innovative portfolio in Iraq, ensuring pre-launch readiness through intensive KOL mapping, engagement, and interactions.
• Advisory Boards: Prepared and executed advisory boards in Iraq, supporting scientific activities at local congresses with both international and regional speakers.
• Tx Guidelines: Developed and executed publication and dissemination plans for treatment guidelines.
• Scientific Leadership: Championed digital innovation in medical education, establishing Sanofi as a preferred partner in immunology and hematology.
• Expert Engagement: Led scientific exchanges and expert engagement strategies, building a potential network through KOL identification, mapping, and profiling.
• Resource Allocation: Made disciplined resource allocations to support core assets, ensuring optimal use of resources.
• Field-Based Medical (FBM) Support: Empowered and involved FBMs in major projects, providing regular scientific support and continuous communication across cross functional and cross-TA (Therapeutic Area) stakeholders.
• Promotional Material Review: Ensured thorough review and validation of 100% promotional materials on PromoMats and events on e-EAF.
• HCP Profiling: Maintained updated classification and profiling of Healthcare Professionals (HCPs) on the BYBLOS grid.
• Collaborative Efforts: Enhanced collaboration and support to partners, including outsourced promotion and external partners.

• Develop Hematology portfolio in Levant (IQ, LB, JO) area with close coordination with
Turkey team
• Prepare and manage oncology pipeline new launches in Levant area (Iraq, Jordan and Lebanon)
• Raise awareness about the prostate cancer disease
• Develop and execute JEVTANA Brand Plan and marketing strategy
• Achieve sales objective and financial KPIs
• Build and maintain strong partnership with KOL
• Coordinate for access to treatment
• Analyze performance for all products in the portfolio, identify growth opportunities and provide solutions to management to face all challenges
• Liaise with sales and medico-marketing teams to develop tactical plans for scaling up products penetration and ensure products availability
• Provide support for evidence-based treatment protocols and pathways

Key Achievements

Responsibilities

•

Key Achievements

Responsibilities

Key Achievements
• Appreciation and recognition letterfor being the First Passion nominee - year 2006
• Achieved market leadership for Seretide in my assigned territories for five years in a row
• Silver award forthe best PAL user - 2006
• Lebanon Outstanding Performers awards and recognitions - 2007, 2008& 2009
• Successfully managed and conducted journal clubs for KOLs in my territory
Responsibilities
• Achieving sales target of Seretie and Flixotide.
• Sales Analysis ofthe Respiratory Asthma market through IMS readings.
• Excelling in selling skills, negation skills and product knowledge.
•